Considering the high risk of recurrence in patients with LNP prostate cancer and the scarcity of relevant studies analyzing LNP prostate cancer patients after RP, further research of salvage treatment may be more important in patients with BCR or persistent elevated PSA. This evidence concerns the gene KLK3 and prostate cancer.